Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
J Thorac Cardiovasc Surg. 2017 May;153(5):1056-1062.e1. doi: 10.1016/j.jtcvs.2016.11.038. Epub 2016 Nov 29.
Native aortic valve calcium and transcatheter aortic valve oversize have been reported to predict pacemaker implantation after transcatheter aortic valve insertion. We reviewed our experience to better understand the association.
We retrospectively reviewed the records of 300 patients with no prior permanent pacemaker implantation who underwent transcatheter aortic valve insertion from November 2008 to February 2015. Valve oversize was calculated using area. The end point of the study was 30-day postoperative pacemaker implantation.
Patient data included age of 81.1 ± 8.4 years, female sex in 135 patients (45%), atrial fibrillation in 74 patients (24.7%), Society of Thoracic Surgeons predicted risk of mortality of 7.6% (interquartile range [IQR], 5.3-10.6), aortic valve calcium score of 2568 (IQR, 1775-3526) Agatston units, and annulus area of 471 ± 82 mm. Balloon-expandable valves were inserted in 244 patients (81.3%). Transcatheter aortic valve oversize was 12.8% (IQR, 3.9-23.3). Pacemaker implantation was performed in 59 patients (19.7%). Aortic valve calcium score (adjusted P = .275) and transcatheter valve oversize (adjusted P = .833) were not independent risk factors for pacemaker implantation when controlling for preoperative right bundle branch block (adjusted odds ratio, 3.49; 95% confidence interval, 1.61-8.55; P = .002), implantation of self-expanding valve (adjusted odds ratio, 4.09; 95% confidence interval, 1.53-10.96; P = .005), left bundle branch block (adjusted P = .331), previous percutaneous coronary intervention (adjusted P = .053), or valve surgery (adjusted P = .111), and PR interval (adjusted P = .350).
Right bundle branch block and implantation of a self-expanding prosthesis were predictive of pacemaker implantation, but not native aortic valve score or transcatheter valve oversize.
据报道,原生主动脉瓣钙和经导管主动脉瓣瓣环过大可预测经导管主动脉瓣置换术后起搏器植入。我们回顾了我们的经验,以更好地理解这种关联。
我们回顾性分析了 2008 年 11 月至 2015 年 2 月期间接受经导管主动脉瓣置换术且术前未植入永久性起搏器的 300 例患者的记录。使用面积计算瓣环过大。研究的终点为术后 30 天内起搏器植入。
患者数据包括年龄 81.1±8.4 岁,女性 135 例(45%),心房颤动 74 例(24.7%),胸外科医生预测死亡率为 7.6%(四分位距 [IQR],5.3-10.6),主动脉瓣钙评分 2568(IQR,1775-3526)Agatston 单位,瓣环面积 471±82mm。244 例(81.3%)患者植入球囊扩张瓣。经导管主动脉瓣瓣环过大 12.8%(IQR,3.9-23.3)。59 例(19.7%)患者行起搏器植入。校正术前右束支阻滞(校正比值比,3.49;95%置信区间,1.61-8.55;P=0.002)、植入自膨式瓣膜(校正比值比,4.09;95%置信区间,1.53-10.96;P=0.005)、左束支阻滞(校正 P=0.331)、经皮冠状动脉介入治疗(校正 P=0.053)或瓣膜手术(校正 P=0.111)和 PR 间期(校正 P=0.350)后,主动脉瓣钙评分和经导管瓣环过大均不是起搏器植入的独立危险因素。
右束支阻滞和自膨式假体植入可预测起搏器植入,但不能预测原生主动脉瓣评分或经导管瓣环过大。